Neuromodulation Market Share, Size, and Outlook by 2031
Neuromodulation Market: Strategic Insights
Neuromodulation Market
-
CAGR (2023 - 2031)15.2% -
Market Size 2021
US$ 8.87 Billion -
Market Size 2031
US$ 28.32 Billion
Market Dynamics
GROWTH DRIVERS
- Growing Developments in Neuromodulation Technology
FUTURE TRENDS
- Technological Advancements
OPPORTUNITIES
- Rising Demand for Neurostimulation Devices to Treat Chronic Pain
Key Players
- Abbott
- Boston Scientific Corporation
- Medtronic
- NeuroPace Inc
- NeuroSigma Inc
- NEVRO CORP
- Synapse Biomedical Inc
- Soterix Medical Inc
- Integer Holdings Corporation
- Magstim
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Technology - External
Application - Chronic Pain Management
- Failed Back Syndrome
- Epilepsy
- Tremor
- Incontinence
- Depression
- Dystonia
- Gastroparesis
- Parkinson Diseases
- Obsessive-Complusive Disorder
- Migraine
End User - Hospitals
- Clinics
- Home Healthcare
Get Free Sample For